2018
DOI: 10.3390/ijms19102926
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Biomarkers for Gestational Diabetes Mellitus

Abstract: Gestational diabetes mellitus (GDM) is a growing public health problem worldwide. The condition is associated with perinatal complications and an increased risk for future metabolic disease in both mothers and their offspring. In recent years, molecular biomarkers received considerable interest as screening tools for GDM. The purpose of this review is to provide an overview of the current status of single-nucleotide polymorphisms (SNPs), DNA methylation, and microRNAs as biomarkers for GDM. PubMed, Scopus, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
80
1
4

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(86 citation statements)
references
References 153 publications
1
80
1
4
Order By: Relevance
“…Currently, screening for GDM is done by using traditional risk factors, [8] the 50 g glucose challenge test (GCT) or an OGTT. [6] A number of other novel screening tests are being explored, including fasting plasma glucose, [9] glycated haemoglobin (HbA1c), [10] cytokines [11] and molecular biomarkers, [12] which are discussed in more detail below. Screening for traditional risk factors remains the cornerstone of screening strategies in low-and middleincome countries due to costs and ease.…”
Section: Screening Testsmentioning
confidence: 99%
See 1 more Smart Citation
“…Currently, screening for GDM is done by using traditional risk factors, [8] the 50 g glucose challenge test (GCT) or an OGTT. [6] A number of other novel screening tests are being explored, including fasting plasma glucose, [9] glycated haemoglobin (HbA1c), [10] cytokines [11] and molecular biomarkers, [12] which are discussed in more detail below. Screening for traditional risk factors remains the cornerstone of screening strategies in low-and middleincome countries due to costs and ease.…”
Section: Screening Testsmentioning
confidence: 99%
“…While genetic variants have been identified in other genes associated with GDM, these were only demonstrated in single populations. [12] The genes identified in ≥2 independent populations include transcription factor 7-like 2 (TCF7L2), adiponectin (ADIPOQ), melatonin-receptor 1B gene (MTNR1B), glucokinase (GCK), glucokinase regulator (GCKR), fat mass and obesity-associated (FTO), insulin-receptor substrate 1 (IRS1) and potassium voltage-gated channel subfamily Q member 1 (KCNQ). Due to variation across different populations, further studies are needed to confirm the association between risk alleles and GDM.…”
Section: Geneticsmentioning
confidence: 99%
“…This is likely due to participation of pregnancy-related hormones, such as human placental lactogen (HPL). A 30-fold increase of HPL by the 20th week of gestation causes improperly elevated blood sugar levels, which contributes to the developing GDM between the second and the third trimester [17,18]. However, women who enter into pregnancy overweight or obese are at a markedly increased risk of developing GDM.…”
Section: Management Of Gestational Diabetes Mellitus During Pregnancymentioning
confidence: 99%
“…Gestational diabetes [6][7][8][9][10][11][12][13][14][15] For the diagnosis of gestational diabetes, oral glucose tolerance test (OGTT) was performed in several steps.…”
Section: Overt Hyperthyroidismmentioning
confidence: 99%